## Answer
(model generated chain of thought explanation)

Given the clinical presentation and laboratory findings, let's analyze the situation step by step:

1. **Clinical Presentation**: The neonate is jaundiced with yellowing of skin and eyes, but his urine and stools are clear. This suggests that the jaundice is not due to gastrointestinal bleeding or infection.

2. **Physical Examination Findings**: Jaundice of the skin and sclerae, a palpable liver (1 cm below the right costal margin), and normal vital signs indicate that the condition is likely related to hemolysis rather than an infectious process.

3. **Laboratory Studies**:
   - Elevated total bilirubin with a significant increase in direct (conjugated) bilirubin suggests hemolytic disease of the newborn (HDN).
   - Normal indirect (unconjugated) bilirubin levels help to rule out certain causes of jaundice, such as biliary atresia or obstruction.
   - The negative Coombs test further supports the diagnosis of HDN.

4. **Risk Factors**: Given that the older sibling had jaundice in the neonatal period and the patient's birth weight is 4000 g (8 lb 8 oz), there may be a genetic predisposition to HDN, such as RhD or Kell disease.

Considering these points, let's evaluate the answer choices:

A. **Intravenous Immunoglobulin (IVIG)**: While IVIG can be used in certain cases of hemolytic disease, it is not typically the first-line treatment for neonatal jaundice due to HDN.

B. **Increase frequency of breast feeds**: This is a reasonable approach as breastfeeding can help reduce the risk of HDN by reducing the amount of bilirubin entering the bloodstream from the mother's blood.

C. **MRI of the brain**: There is no indication that the neonate has neurological symptoms or signs, and an MRI would not be the most appropriate next step in management for this presentation.

D. **Phototherapy**: Phototherapy can help reduce bilirubin levels but may not address the underlying cause of HDN. It's also typically used as a bridge therapy until other treatments become available.

Therefore, considering the clinical presentation, laboratory findings, and risk factors, the most appropriate next step in management is to increase the frequency of breast feeds to reduce the amount of bilirubin entering the bloodstream from the mother's blood